연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
567. Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.
Park SR, Baek JY, Kim DW, Im SA, Kim TY, Bang YJ, Kim NK, Jeon YK, Kim CW, Heo DS.
J Korean Med Sci. 2006 Aug;21(4):633-8.
Link
566. Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients.
Han SW, Kim TY, Lee KH, Hwang PG, Jeon YK, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Heo DS, Bang YJ.
Lung Cancer. 2006 Nov;54(2):201-7. Epub 2006 Sep 7.
Link
565. Patient-reported assessment of quality care at end of life: development and validation of Quality Care Questionnaire-End of Life (QCQ-EOL).
Yun YH, Kim SH, Lee KM, Park SM, Lee CG, Choi YS, Lee WS, Kim SY, Heo DS.
Eur J Cancer. 2006 Sep;42(14):2310-7. Epub 2006 Aug 8.
Link
564. Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors.
Lim MJ, Min SH, Lee JJ, Kim IC, Kim JT, Lee DC, Kim NS, Jeong S, Kim MN, Kim KD, Lim JS, Han SB, Kim HM, Heo DS, Yeom YI.
Mol Ther. 2006 May;13(5):899-909. Epub 2006 Feb 3
Link
563. Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience.
Kim JH, Kim SY, Jung KH, Park K, Suh CW, Lim HY, Kim YH, Ryoo BY, Cho EK, Park BJ, Heo DS.
Lung Cancer. 2006 Apr;52(1):75-81. Epub 2006 Feb 20.
Link
562. Enhanced Specificity of the p53 Family Proteins-Based Adenoviral Gene Therapy in Uterine Cervical Cancer Cells with E2F1-Responsive Promoters.
Lee JJ, Kim S, Yeom YI, Heo DS.
Cancer Biol Ther. 2006 Nov 19;5(11) [Epub ahead of print]
Link
561. Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients.
Han, S. W. Kim, T. Y. Lee, K. H. Hwang, P. G. Jeon, Y. K. Oh, D. Y. Lee, S. H. Kim, D. W. Im, S. A. Chung, D. H. Heo, D. S. Bang, Y. J.
Lung Cancer 2006; 54:201-207.
Link
560. Cancer cell-derived IL-1alpha induces IL-8 release in endothelial cells.
Rhim JH, Kim SA, Lee JE, Kim DJ, Chung HK, Shin KJ, Chung J.
J Cancer Res Clin Oncol. 2008 Jan;134(1):45-50
Link
559. Generation of a rabbit V(H) domain antibody polyspecific c-Met and adenoviral knob protein.
Im SY, Kim KS, Yun CO, Kim JH, Yi KS, Chung J.
Biochem Biophys Res Commu 2006;339(1):305-312.
Link
558. High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
Lee KH, Lee SH, Kim DW, Kang WJ, Chung JK, Im SA, Kim TY, Kim YW, Bang YJ, Heo DS.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4232-6.
Link